2011 marked the beginning of a six-year "patent cliff" that will see record-breaking expiries of "blockbuster" drugs sold by international pharmaceutical giants. According to Datamonitor: 'The 2011 “patent cliff” is expected to erode $78 billion in global sales from brand drugs with patents set to expire anywhere from 2010 to 2014'.

With this in mind, it has never been a more important time to ensure that you have a robust application and litigation strategy in place in order to be able to extend your market exclusivity, establish your own IP position and protect your existing patents.

Pharma IQ's 7th Annual Developing IP Strategies for Crystalline Forms is the only event of its kind that will directly address the unique challenges involved in patenting crystalline forms. It will provide practical solutions to the most common problems in patent application and expert insights into successful litigation strategies.

Join us to learn more about the application requirements from different regions, to discuss the latest case laws and court rulings and to hear from the leading experts in this field.